Allstate (ALL)
(Delayed Data from NYSE)
$195.37 USD
-0.14 (-0.07%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $195.45 +0.08 (0.04%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$195.37 USD
-0.14 (-0.07%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $195.45 +0.08 (0.04%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Zacks News
Allstate (ALL) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the most recent trading session, Allstate (ALL) closed at $186.10, indicating a +0.93% shift from the previous trading day.
Allstate (ALL) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Progressive Stock Moves Above 50-Day SMA: What Should Investors Know?
by Tanuka De
PGR seems well poised on improving premiums, steady policy life expectancy, investment in technology and a solid capital position.
Travelers Stock Trading Near 52-Week High: What Investors Should Know
by Tanuka De
TRV is set to gain from continued strong renewal rate change, retention, increase in new business, solid market presence and growing commercial businesses.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Allstate (ALL) Up 6.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Allstate (ALL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Smart Investors Are Holding Allstate Stock Now: Here's Why
by Zacks Equity Research
With inflation easing, the strong pricing environment will benefit ALL's shareholders.
Here's Why Allstate (ALL) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Allstate (ALL) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Allstate (ALL) Estimates $226M Initial Loss From Hurricane Beryl
by Zacks Equity Research
Allstate's (ALL) estimated catastrophe losses for July are $587 million from 20 events.
The Zacks Analyst Blog Highlights Arch Capital, The Allstate, The Progressiv, RLI and Root
by Zacks Equity Research
Arch Capital, The Allstate, The Progressiv, RLI and Root are part of the Zacks top Analyst Blog.
Allstate (ALL) to Sell Employer Voluntary Benefits Unit for $2B
by Zacks Equity Research
Allstate's (ALL) plan to sell its Employer Voluntary Benefits business to The Standard is expected to boost deployable capital by $1.6 billion. The move aligns with ALL's strategy to focus on its core operations.
Buy 5 Property & Casualty Insurers to Enhance Your Portfolio
by Nalak Das
We have narrowed our search to five P&C insurers with strong potential for the rest of 2024. These are: ACGL, ALL, PGR, RLI, ROOT.
Is Progressive (PGR) Still Worth Buying Post Q2 Earnings?
by Tanuka De
Progressive (PGR) seems well-poised on improving premiums, steady policy life expectancy, investment in technology and a solid capital position.
Recent Volatility Indicates a Base Formation: Top 5 Picks
by Nalak Das
We have narrowed our search to five growth stocks that have solid upside left for the rest of 2024. These are: ALL, DECK, VRT, RCL, PWR.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
Is Acadia Realty Trust (AKR) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Acadia Realty Trust (AKR) and Allstate (ALL) have performed compared to their sector so far this year.
Wall Street Bulls Look Optimistic About Allstate (ALL): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Allstate (ALL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Allstate (ALL) Q2 Earnings Beat on Property-Liability Rate Hikes
by Zacks Equity Research
Allstate (ALL) witnesses lower property and casualty insurance claims and claims expenses in the second quarter.
Allstate (ALL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Allstate (ALL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Allstate (ALL) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Allstate (ALL) delivered earnings and revenue surprises of 387.88% and 1.69%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Berkshire (BRK.B) Pre-Q2 Earnings Analysis: To Buy or Hold?
by Tanuka De
Berkshire's (BRK.B) insurance business is likely to be affected by overactive hurricane season, though better performance of its other businesses should offer respite.
Can Allstate (ALL) Q2 Earnings Beat Estimates on Premium Growth?
by Zacks Equity Research
Allstate's (ALL) second-quarter results are likely to reflect growing net investment income.
Q2 Beat or Miss: What's Ahead for These 5 Insurance Stocks?
by Kaibalya Pravo Dey
Improving business environment, underwriting practices and other factors are expected to have benefited insurance players in the second quarter. MET, AFL, AIG, ALL and EG will release earnings on Jul 31.